These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9398823)

  • 21. Pharmacological, pharmacokinetic and clinical properties of olopatadine hydrochloride, a new antiallergic drug.
    Ohmori K; Hayashi K; Kaise T; Ohshima E; Kobayashi S; Yamazaki T; Mukouyama A
    Jpn J Pharmacol; 2002 Apr; 88(4):379-97. PubMed ID: 12046981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model.
    Greiner JV; Udell IJ
    Clin Ther; 2005 May; 27(5):568-77. PubMed ID: 15978305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of topical ophthalmic epinastine and olopatadine on tear volume in mice.
    Villareal AL; Farley W; Pflugfelder SC
    Eye Contact Lens; 2006 Dec; 32(6):272-6. PubMed ID: 17099387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Olopatadine 0.2% ophthalmic solution: the first ophthalmic antiallergy agent with once-daily dosing.
    Abelson MB; Gomes PJ
    Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):453-61. PubMed ID: 18433347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ophthalmic levocabastine for allergic conjunctivitis.
    Med Lett Drugs Ther; 1994 Apr; 36(920):35-6. PubMed ID: 7908401
    [No Abstract]   [Full Text] [Related]  

  • 26. A review of the use of olopatadine in allergic conjunctivitis.
    McGill JI
    Int Ophthalmol; 2004 May; 25(3):171-9. PubMed ID: 15847317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of ketotifen fumarate, olopatadine, and levocabastine on ocular active anaphylaxis in the guinea pig and ocular immediate hypersensitivity in the albino rat.
    Schoch C
    Ocul Immunol Inflamm; 2005 Feb; 13(1):39-44. PubMed ID: 15804768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and comfort of olopatadine 0.2% versus epinastine 0.05% ophthalmic solution for treating itching and redness induced by conjunctival allergen challenge.
    Mah FS; Rosenwasser LJ; Townsend WD; Greiner JV; Bensch G
    Curr Med Res Opin; 2007 Jun; 23(6):1445-52. PubMed ID: 17559743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Olopatadine (AL-4943A): ligand binding and functional studies on a novel, long acting H1-selective histamine antagonist and anti-allergic agent for use in allergic conjunctivitis.
    Sharif NA; Xu SX; Yanni JM
    J Ocul Pharmacol Ther; 1996; 12(4):401-7. PubMed ID: 8951676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Misleading advertisement on Opatanol].
    Timmermans AE
    Ned Tijdschr Geneeskd; 2006 Jul; 150(26):1472. PubMed ID: 16875272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of olopatadine for the treatment of ocular allergy.
    Abelson MB
    Expert Opin Pharmacother; 2004 Sep; 5(9):1979-94. PubMed ID: 15330735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elestat (epinastine HCl ophthalmic solution 0.05%) as a therapeutic for allergic conjunctivitis.
    Trattler WB; Luchs J; Majmudar P
    Int Ophthalmol Clin; 2006; 46(4):87-99. PubMed ID: 17060795
    [No Abstract]   [Full Text] [Related]  

  • 33. Epinastine in the management of ocular allergic disease.
    Friedlaender MH
    Int Ophthalmol Clin; 2006; 46(4):85-6. PubMed ID: 17060794
    [No Abstract]   [Full Text] [Related]  

  • 34. Olopatadine hydrochloride ophthalmic solution for the treatment of allergic conjunctivitis.
    Gonzalez-Estrada A; Reddy K; Dimov V; Eidelman F
    Expert Opin Pharmacother; 2017 Aug; 18(11):1137-1143. PubMed ID: 28656804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [An open and controlled study of effectiveness and tolerance of Livostin eyedrops].
    Stara J; Krásný J; Plísková S; Síblová O
    Cesk Slov Oftalmol; 1997 Feb; 53(1):46-8. PubMed ID: 9213524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of emedastine eyedrops on acute seasonal allergic conjunctivitis in children].
    Endre L
    Orv Hetil; 2003 Apr; 144(14):665-7. PubMed ID: 12795028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Alomide eyedrops in the treatment of allergic conjunctivitis and keratoconjunctivitis].
    Maĭchuk IuF; Khaitova KN; Grishakova MB
    Vestn Oftalmol; 1998; 114(4):43-4. PubMed ID: 9771090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacological profile and clinical efficacy of olopatadine hydrochloride ophthalmic solution (Patanol 0.1% ophthalmic solution)].
    Watanabe M; Kodama H; Hasegawa K; Itoh K
    Nihon Yakurigaku Zasshi; 2007 Sep; 130(3):221-31. PubMed ID: 17878619
    [No Abstract]   [Full Text] [Related]  

  • 39. Ocular allergy treatment comparisons: azelastine and olopatadine.
    Bielory L; Buddiga P; Bigelson S
    Curr Allergy Asthma Rep; 2004 Jul; 4(4):320-5. PubMed ID: 15175148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of olopatadine hydrochloride on the number of scratching induced by repeated application of oxazolone in mice.
    Tamura T; Amano T; Ohmori K; Manabe H
    Eur J Pharmacol; 2005 Nov; 524(1-3):149-54. PubMed ID: 16259975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.